Literature DB >> 2757144

The right retroperitoneal approach for abdominal aortic surgery.

B B Chang1, P S Paty, D M Shah, R P Leather, J L Kaufman, W R McClellan.   

Abstract

Retroperitoneal exposure of the abdominal aorta is usually performed through a left flank incision. An alternative approach to the abdominal aorta is described utilizing a right flank incision. Indications for the use of the right retroperitoneal approach during surgery for aortic aneurysms include right renal artery stenosis, right iliac artery aneurysm, need for simultaneous cholecystectomy, multiple or recent intraabdominal procedures, and sigmoid colostomy. A series of 17 patients is presented to illustrate the utility of this approach. There was one operative death in an emergent patient; the cause of death was not related to the method of aortic exposure. The remaining patients recovered quickly. The anatomic advantages and limitations of this exposure are discussed. We believe that retroperitoneal aortic exposure is superior to midline transperitoneal exposure. Aortic exposure utilizing a right retroperitoneal approach is a useful option in the surgical armamentarium.

Entities:  

Mesh:

Year:  1989        PMID: 2757144     DOI: 10.1016/0002-9610(89)90366-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

Review 1.  Surgical treatment of abdominal aortic aneurysm in association with horseshoe kidney. Three case reports and a review of technique.

Authors:  G Canova; R Masini; E Santoro; S Bartolomeo; C Martini; G Becchi
Journal:  Tex Heart Inst J       Date:  1998

2.  Current status of the use of retroperitoneal approach for reconstructions of the aorta and its branches.

Authors:  C Darling; D M Shah; B B Chang; P S Paty; R P Leather
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

3.  Advantages of using the midline incision right retroperitoneal approach for abdominal aortic aneurysm repair.

Authors:  M Endo; K Kobayashi; M Tsubota; M Seki; H Sato; T Noto; T Iwa
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.